UPDATE : Monday, December 10, 2018
상단여백
LG Chem to work on bilayer tablet for diabetes, dyslipidemia
LG Chem said it would start developing bilayer tablets of Zemiro (gemiglipt...
by Lee Hye-seon  |  2018-11-06 11:06
라인
Celltrion wins suit against Roche to invalidate Herceptin patent in Japan
Korea’s biosimilar company Celltrion is likely to accelerate its move to ex...
by So Jae-hyeon  |  2018-11-05 15:26
라인
GC starts developing shingles vaccine in US
GC said Monday that its U.S. subsidiary Cuervo has received U.S. Food and D...
by Lee Han-soo  |  2018-11-05 13:31
라인
Lilly Korea’s rheumatoid arthritis treatment wins insurance coverage
Lilly Korea said Thursday that it has gained reimbursement for its rheumato...
by Lee Han-soo  |  2018-11-02 17:52
라인
Why did pharmaceuticals release hair loss drugs in tablet form?
Why have Korean pharmaceutical companies released hair loss treatments in t...
by So Jae-hyeon  |  2018-11-02 12:43
라인
Genexine wins FDA nod for clinical trials of HyLeukin-7
Genexine and NeoImmuneTech have received approval from the U.S. Food and Dr...
by Lee Han-soo  |  2018-11-01 11:03
라인
Acer submits new drug application for rare disease to FDA
Acer Therapeutics, a NASDAQ-listed pharmaceutical firm in which Bukwang Pha...
by Park Gi-taek  |  2018-10-31 15:55
라인
Korea’s drug exports to US inch down this year
Korea’s exports of pharmaceutical products to the U.S. slightly went down i...
by Nam Doo-hyun  |  2018-10-31 12:22
라인
Dong-A ST’s Q-3 sales slid to ₩140.8 billion
Dong-A ST said Tuesday that it recorded sales of 140.8 billion won ($123.5 ...
by Lee Han-soo  |  2018-10-31 11:46
라인
Hanmi’s leukemia drug candidate wins FDA’s orphan drug status
Hanmi Pharmaceutical said Wednesday that its HM43239, a drug candidate in t...
by Lee Han-soo  |  2018-10-31 11:45
라인
GC’s Q3 sales fell to ₩352.3 billion won
GC said Tuesday that the company and its subsidiaries recorded 352.3 billio...
by Lee Han-soo  |  2018-10-30 17:00
라인
[Exclusive] Patent of osteoarthritis drug Invossa refused in Europe
Kolon TissueGene has failed to obtain a patent for Korea’s 29th novel drug ...
by Nam Doo-hyun  |  2018-10-30 16:04
라인
Hanmi’s partner gets FDA nod for testing oral breast cancer treatment
Hanmi Pharmaceutical said Tuesday that Athenex, its U.S. partner, has recei...
by Lee Han-soo  |  2018-10-30 16:00
라인
Generics threaten originals in dementia drug market
Generic products are showing tremendous growth in the market of Donepezil, ...
by So Jae-hyeon  |  2018-10-30 14:18
라인
Hanmi posts ₩235.3 billion in Q3 sales
Hanmi Pharmaceutical said Monday that it recorded sales of 235.3 billion wo...
by Lee Han-soo  |  2018-10-30 11:14
라인
ViiV Healthcare asks FDA to approve new HIV treatment
ViiV Healthcare has submitted a new drug application (NDA) to the U.S. Food...
by Lee Han-soo  |  2018-10-29 16:53
라인
‘Foreign investors fear Korean botox sales decline in China’
Foreign institutional investors fear that Korean makers of botulinum toxin ...
by Nam Doo-hyun  |  2018-10-29 16:52
라인
HanAll releases test results for dry eye treatment in US
HanAll Biopharma said Monday it has presented phase 2 clinical trial result...
by Lee Han-soo  |  2018-10-29 16:08
라인
JW invests in Argonaut Therapeutics
JW Pharmaceutical said Monday that it has signed a strategic investment agr...
by Lee Han-soo  |  2018-10-29 11:16
라인
AbbVie unveils P2-b clinical trial results for ulcerative colitis treatment
AbbVie said Friday that it has produced positive results from U-ACHIEVE, an...
by Lee Han-soo  |  2018-10-26 17:44
여백
여백
여백
Back to Top